Assignee
INSTITUTE FOR CANCER RES
US·43 granted patents·21 citations·filing 2014–2024
Top patents by PatentIndex Score
43 records- 0188US10987356B2Dual inhibition of CDK and HSP90 destabilize H1F1 α and synergistically induces cancer cell deathINSTITUTE FOR CANCER RES·Filed 2019·Granted Apr 27, 2021·2 cites·19 claims
- 0283US12226105B2Tensionable surgical clampINSTITUTE FOR CANCER RES·Filed 2023·Granted Feb 18, 2025·1 cites·14 claims
- 0383US11578324B2miR-3132 upregulation of the TRAIL pathway and apoptotic activity in cancer cellsINSTITUTE FOR CANCER RES·Filed 2019·Granted Feb 14, 2023·2 cites·13 claims
- 0481US12595483B2Treatment of tumors with miRNA targeting CDK4/CDK6INSTITUTE FOR CANCER RES·Filed 2023·Granted Apr 7, 2026·0 cites·4 claims
- 0581US12344599B2Prodigiosin analogs and methods of useINSTITUTE FOR CANCER RES·Filed 2024·Granted Jul 1, 2025·0 cites·16 claims
- 0681US10220051B2Combination of DNA repair inhibition with bendamustine or gemcitabine in the treatment of cancerINSTITUTE FOR CANCER RES·Filed 2014·Granted Mar 5, 2019·3 cites·12 claims
- 0778US11993589B2Prodigiosin analogs and methods of useINSTITUTE FOR CANCER RES·Filed 2022·Granted May 28, 2024·0 cites·8 claims
- 0878US11077121B2Inhibition of thymine DNA glycosylase in the treatment of cancerINSTITUTE FOR CANCER RES·Filed 2016·Granted Aug 3, 2021·2 cites·17 claims
- 0977US10328050B2C-Myc as a biomarker for tumor sensitivity to treatment with RNA polymerase II inhibitionINSTITUTE FOR CANCER RES·Filed 2018·Granted Jun 25, 2019·1 cites·14 claims
- 1076US10724100B2Systems and methods for treating patients having a genetic predisposition to develop prostate cancerINSTITUTE FOR CANCER RES·Filed 2015·Granted Jul 28, 2020·2 cites·22 claims
- 1175US10550108B2Poly(ADP-ribose) polymerase 1 inhibitors structurally unrelated to NADINSTITUTE FOR CANCER RES·Filed 2015·Granted Feb 4, 2020·3 cites·22 claims
- 1274US10729692B2Dual inhibition of CDK and HSP90 destabilize HIF1alpha and synergistically induces cancer cell deathINSTITUTE FOR CANCER RES·Filed 2018·Granted Aug 4, 2020·1 cites·5 claims
- 1373US12071622B2miR-3132 upregulation of the trail pathway and apoptotic activity in cancer cellsINSTITUTE FOR CANCER RES·Filed 2023·Granted Aug 27, 2024·0 cites·11 claims
- 1473US9889141B2Combined inhibition of the vitamin D receptor and poly(ADP) ribose polymerase (PARP) in the treatment of cancerINSTITUTE FOR CANCER RES·Filed 2015·Granted Feb 13, 2018·1 cites·5 claims
- 1572US11203598B2Compounds for repressing cancer cell growthINSTITUTE FOR CANCER RES·Filed 2019·Granted Dec 21, 2021·1 cites·4 claims
- 1671US11859183B2Treatment of tumors with miRNA targeting CDK4/CDK6INSTITUTE FOR CANCER RES·Filed 2021·Granted Jan 2, 2024·0 cites·8 claims
- 1769US11944319B2Tensionable surgical clampINSTITUTE FOR CANCER RES·Filed 2019·Granted Apr 2, 2024·2 cites·13 claims
- 1868US11535608B2Prodigiosin analogs and methods of useINSTITUTE FOR CANCER RES·Filed 2020·Granted Dec 27, 2022·0 cites·18 claims
- 1965US10870640B2Prodigiosin analogs and methods of useINSTITUTE FOR CANCER RES·Filed 2019·Granted Dec 22, 2020·0 cites·19 claims
- 2063US11034959B2Treatment of tumors with miRNA targeting CDK4/CDK6INSTITUTE FOR CANCER RES·Filed 2018·Granted Jun 15, 2021·0 cites·8 claims
- 2162US11883413B2Inhibition of thymine DNA glycosylase in the treatment of cancerINSTITUTE FOR CANCER RES·Filed 2021·Granted Jan 30, 2024·0 cites·7 claims
- 2262US11389455B2Inhibitors of HIV-1 integrase multimerizationINSTITUTE FOR CANCER RES·Filed 2020·Granted Jul 19, 2022·0 cites·14 claims
- 2361US10449200B2Combined inhibition of the vitamin D receptor and poly(ADP) ribose polymerase (PARP) in the treatment of cancerINSTITUTE FOR CANCER RES·Filed 2017·Granted Oct 22, 2019·0 cites·20 claims
- 2459US10888564B2Inhibitors of HIV-1 integrase multimerizationINSTITUTE FOR CANCER RES·Filed 2018·Granted Jan 12, 2021·0 cites·8 claims
- 2555US12098428B2Frequent EGFR and NTRK somatic mutations in colorectal cancer (CRC) with microsatellite instability (MSI)INSTITUTE FOR CANCER RES·Filed 2018·Granted Sep 24, 2024·0 cites·14 claims
- 2652US10436795B2Carbon-detected NMR for mapping binding sites in intrinsically disordered regions of a proteinINSTITUTE FOR CANCER RES·Filed 2017·Granted Oct 8, 2019·0 cites·15 claims
- 2752US9993458B2Method of treating MYC-amplified tumors with RNA-polymerase II inhibitorsINSTITUTE FOR CANCER RES·Filed 2016·Granted Jun 12, 2018·0 cites·5 claims
- 2850US12377235B2Multipurpose deviceINSTITUTE FOR CANCER RES·Filed 2019·Granted Aug 5, 2025·0 cites·17 claims
- 2948US12240897B2Treatment of non-alcoholic steatohepatitis (NASH) with IL-27 antibodyINSTITUTE FOR CANCER RES·Filed 2021·Granted Mar 4, 2025·0 cites·7 claims
- 3048US11697674B2Human chorionic gonadotropin variant peptides and treatment of breast cancerINSTITUTE FOR CANCER RES·Filed 2018·Granted Jul 11, 2023·0 cites·10 claims
- 3148US10584353B2P21-activated kinase inhibitor domain targeted transgenic mouseINSTITUTE FOR CANCER RES·Filed 2017·Granted Mar 10, 2020·0 cites·7 claims
- 3247US12576075B2Combination therapies for treating cancerINSTITUTE FOR CANCER RES·Filed 2019·Granted Mar 17, 2026·0 cites·5 claims
- 3347US11332756B2RNA virus vectors carrying DAI and RIPK3INSTITUTE FOR CANCER RES·Filed 2017·Granted May 17, 2022·0 cites·5 claims
- 3445US12539405B2Hematostick/HematoDartINSTITUTE FOR CANCER RES·Filed 2019·Granted Feb 3, 2026·0 cites·14 claims
- 3543US12369787B2Bronchoscope tip marker for orientation of radial endobronchial ultrasound probeINSTITUTE FOR CANCER RES·Filed 2021·Granted Jul 29, 2025·0 cites·11 claims
- 3642US11578370B2Methods for diagnosis and treatment of patients having solid tumorsINSTITUTE FOR CANCER RES·Filed 2018·Granted Feb 14, 2023·0 cites·11 claims
- 3741US12098193B2Netrin G1 as a biomarker for enhancing tumor treatment efficacyINSTITUTE FOR CANCER RES·Filed 2018·Granted Sep 24, 2024·0 cites·4 claims
- 3840US11587229B2Retained surgical itemsINSTITUTE FOR CANCER RES·Filed 2020·Granted Feb 21, 2023·0 cites·18 claims
- 3940US10472664B2Screening assay for identification of poly(ADP-ribose) polymerase 1 inhibitorsINSTITUTE FOR CANCER RES·Filed 2015·Granted Nov 12, 2019·0 cites·10 claims
- 4038US10654801B2Prodigiosin analogsINSTITUTE FOR CANCER RES·Filed 2017·Granted May 19, 2020·0 cites·8 claims
- 4137US12465637B2Compositions and methods for modulation of antibody activityINSTITUTE FOR CANCER RES·Filed 2020·Granted Nov 11, 2025·0 cites·26 claims
- 4234US11240996B2Mice with transgene of iBox peptide inhibitor of group B p21-activated kinasesINSTITUTE FOR CANCER RES·Filed 2017·Granted Feb 8, 2022·0 cites·9 claims
- 4333US10724051B2Methods for enriching gene-targeted cellsINSTITUTE FOR CANCER RES·Filed 2017·Granted Jul 28, 2020·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when INSTITUTE FOR CANCER RES files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →